Funder: Breakthrough T1D

Due Dates: October 29, 2025: Letter of Intent deadline | January 13, 2026: Full proposal deadline

Funding Amounts: Up to $3,000,000 total for up to 3 years; actual amounts may vary based on project scope and justification.

Summary: Supports clinical trials to develop or improve therapies for cardiovascular disease in people with type 1 diabetes, aiming to enhance treatment and outcomes.

Key Information: LOI required; both academic and industry-led trials eligible; proposals must include people with T1D.